The MARC Education Core emphasizes the a) development of synergy between MARC's pre-clinical and clinical investigators and b) creation of translational research experiences for pre-clinical and clinical residents and fellows. The Education Core's renewal application recognizes that multiple disciplines benefit from systematic training and embraces a diversity of clinical trainees and healthcare professionals interested in addressing the use methamphetamines (MAs) and other drugs. The MARC's pre-clinical and clinical research provides a foundation for improving healthcare and addiction treatment for women and men struggling with methamphetamine abuse and dependence. We also offer media training to help pre-clinical and clinical investigators improve communication skills, work more effectively with print and video reporters, and enhance the public image of the MARC. An expansion of media training includes more MARC investigators and NIDA-funded investigators at OHSU. Finally, the Education Core develops innovative participatory exhibits that help the public understand addiction as a brain disease, and the contributions of human and animal studies to more effective treatments for methamphetamine and drug addiction. The MARC Education Core has two specific aims: training and outreach.
Aim 1 : Enhance the training environment and establish strategic partnerships between lab-based drug abuse research and drug treatment and intervention (including trainees in basic and clinical research and both future and practicing healthcare providers).
Aim 2 : Disseminate public education tools developed for training scientists to talk with the public and create unique exhibits that actively engage the public in NIH research. The Education Core's innovative training and outreach strategies support the professional development of MARC investigators (invited speakers, seminars, and meetings) and translate the neuroscience of addiction to the general public and to the community of science (media training and participatory citizen science exhibits).
The Education Core is dedicated to training and outreach. We support professional development of investigators and clinicians. We enhance public outreach and communication via media training and interactive exhibits to make clear the significance of our scientific discoveries. The Core continues to support conferences for current and future health-care providers on emerging neuroscience and addiction.
|Szumlinski, Karen K; Lominac, Kevin D; Campbell, Rianne R et al. (2016) Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly. Biol Psychiatry :|
|Li, Minghua; Underhill, Suzanne M; Reed, Cheryl et al. (2016) Amphetamine and Methamphetamine Increase NMDAR-GluN2B Synaptic Currents in Midbrain Dopamine Neurons. Neuropsychopharmacology :|
|Lominac, Kevin D; Quadir, Sema G; Barrett, Hannah M et al. (2016) Prefrontal glutamate correlates of methamphetamine sensitization and preference. Eur J Neurosci 43:689-702|
|Loftis, Jennifer M; Lim, Miranda M (2016) Sleep disturbance in substance use disorders and comorbid chronic viral infections. Addiction 111:1093-4|
|Ellis, Carilyn; Hoffman, William; Jaehnert, Sarah et al. (2016) Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction. Addict Disord Their Treat 15:1-5|
|Kim, Hyunjee; Hartung, Daniel M; Jacob, Reside L et al. (2016) The Concentration of Opioid Prescriptions by Providers and Among Patients in the Oregon Medicaid Program. Psychiatr Serv 67:397-404|
|Janowsky, Aaron; Tosh, Dilip K; Eshleman, Amy J et al. (2016) Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine. J Pharmacol Exp Ther 357:24-35|
|Greenberg, G D; Huang, L C; Spence, S E et al. (2016) Nest building is a novel method for indexing severity of alcohol withdrawal in mice. Behav Brain Res 302:182-90|
|Zou, Mu-Fa; Keck, Thomas M; Kumar, Vivek et al. (2016) Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity. J Med Chem 59:2973-88|
|Abraham, Antony D; Neve, Kim A; Lattal, K Matthew (2016) Effects of D1 receptor knockout on fear and reward learning. Neurobiol Learn Mem 133:265-73|
Showing the most recent 10 out of 120 publications